Public Comment on Draft Recommendation Statement: Low-dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia

Public Comment on Draft Recommendation Statement: Low-dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia

Public Comment on Draft Recommendation Statement: Low-dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia

Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 04/08/2014 08:00 AM EDT

The U.S. Preventive Services Task Force posted today its draft Recommendation Statement on low-dose aspirin for the prevention of morbidity and mortality from preeclampsia for public comment. The draft Recommendation Statement is available for review and public comment from April 8 through May 5, 2014. To review the draft Recommendation Statement and submit comments, go tohttp://www.uspreventiveservicestaskforce.org/tfcomment.htm.